EA201690908A1 - Pyrazolopyrmidine compounds - Google Patents
Pyrazolopyrmidine compoundsInfo
- Publication number
- EA201690908A1 EA201690908A1 EA201690908A EA201690908A EA201690908A1 EA 201690908 A1 EA201690908 A1 EA 201690908A1 EA 201690908 A EA201690908 A EA 201690908A EA 201690908 A EA201690908 A EA 201690908A EA 201690908 A1 EA201690908 A1 EA 201690908A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pyrazolopyrmidine
- compounds
- methods
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
В настоящем изобретении предложено соединение, представленное следующей структурной формулой:или его фармацевтически приемлемая соль. Также описаны фармацевтические композиции и способы их применения.The present invention provides a compound represented by the following structural formula: or a pharmaceutically acceptable salt thereof. Also described pharmaceutical compositions and methods for their use.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CA2013/000957 WO2014075168A1 (en) | 2012-11-16 | 2013-11-15 | Pyrazolopyrimidine compounds |
PCT/CA2014/051091 WO2015070349A1 (en) | 2012-11-16 | 2014-11-14 | Pyrazolopyrimidine compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201690908A1 true EA201690908A1 (en) | 2016-09-30 |
EA029372B1 EA029372B1 (en) | 2018-03-30 |
Family
ID=56617958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201690908A EA029372B1 (en) | 2013-11-15 | 2014-11-14 | Pyrazolopyrimidine compounds |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP6095857B2 (en) |
EA (1) | EA029372B1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2017299850B2 (en) * | 2016-07-18 | 2021-05-27 | University Health Network | Solid forms of TTK inhibitor |
CA3101035A1 (en) * | 2018-05-23 | 2019-11-28 | University Health Network | Methods of treating cancers characterized by a high expression level of spindle and kinetochore associated complex subunit 3 (ska3) gene |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004052315A2 (en) * | 2002-12-11 | 2004-06-24 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
US20070179161A1 (en) * | 2003-03-31 | 2007-08-02 | Vernalis (Cambridge) Limited. | Pyrazolopyrimidine compounds and their use in medicine |
ES2339670T3 (en) * | 2003-12-23 | 2010-05-24 | Novartis Ag | BICYCLE HYPERCYCLIC INHIBITORS OF QUINASA P-38. |
EP1942900B1 (en) * | 2005-10-06 | 2015-06-03 | Merck Sharp & Dohme Corp. | Use of pyrazolo [1,5-a] pyrimidine derivatives for inhibiting kinases methods for inhibiting protein kinases |
EP1873157A1 (en) * | 2006-06-21 | 2008-01-02 | Bayer Schering Pharma Aktiengesellschaft | Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
AU2008279759A1 (en) * | 2007-07-20 | 2009-01-29 | Merck & Co., Inc. | Pyrazolo[1,5-a]pyrimidine derivatives |
CA2801031A1 (en) * | 2010-06-01 | 2011-12-08 | Bayer Intellectual Property Gmbh | Substituted imidazopyrazines |
EP2651945A1 (en) * | 2010-12-17 | 2013-10-23 | Bayer Intellectual Property GmbH | 6-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders |
JP2014503521A (en) * | 2010-12-17 | 2014-02-13 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Imidazopyrazines for use as MPS-1 and TKK inhibitors in the treatment of hyperproliferative disorders |
ES2545135T3 (en) * | 2011-04-06 | 2015-09-08 | Bayer Pharma Aktiengesellschaft | Substituted Imidazopyridines and intermediates thereof |
CA2889919C (en) * | 2012-11-16 | 2021-08-17 | University Health Network | Pyrazolopyrimidine compounds |
-
2014
- 2014-11-14 EA EA201690908A patent/EA029372B1/en not_active IP Right Cessation
- 2014-11-14 JP JP2016530227A patent/JP6095857B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP6095857B2 (en) | 2017-03-15 |
EA029372B1 (en) | 2018-03-30 |
JP2016537354A (en) | 2016-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120635T1 (en) | AMINOETERALYL BENZAMIDS AS KINASE INhibitors | |
CY1120480T1 (en) | PYRAZOLOPYRIMIDINE COMPOUNDS | |
PH12015502031A1 (en) | Tetrahydropyrrolothiazine compounds | |
EA201890899A1 (en) | PHARNESIDE X-RECEPTOR MODULATORS | |
EA201791420A1 (en) | TRIAZOLOPYRIMIDIN COMPOUNDS AND THEIR APPLICATIONS | |
RS54730B1 (en) | Inhibitors of beta-secretase | |
EA201790407A1 (en) | PROBES FOR VISUALIZATION PROTEIN HANTINGTIN | |
EA201591634A1 (en) | DIHYDROPYRIDOPYRIMIDINE COMPOUNDS | |
EA201690473A1 (en) | COMBINED COMPOSITION OF TWO ANTI-VIRUS COMPOUNDS | |
EA201591805A1 (en) | OXABICICLO [2.2.2] ACIDS - MODULATORS GPR120 | |
EA201492287A1 (en) | DEUTERED DERIVATIVES RUXOLITINIBA | |
EA201690764A1 (en) | INHIBITOR GRELIN-O-Aciltransferase | |
EA201690911A1 (en) | COMPOUNDS OF DIMETHYLBENE ACID | |
EA201500931A1 (en) | PYRIDIN-4-ILA DERIVATIVES | |
EA201490761A1 (en) | R (+) - N-Formylpropylglycinone | |
EA201590552A1 (en) | AMINOHINOLINES AS KINASE INHIBITORS | |
EA201592268A1 (en) | DIHYDROPYRIDINONE INHIBITORS MGAT2 | |
CY1124251T1 (en) | CARBOXAMIDE DERIVATIVES | |
EA201790400A1 (en) | PROBES FOR VISUALIZATION PROTEIN HANTINGTIN | |
EA201591915A1 (en) | COMPOUNDS OF PHENOXYETHYL DIHYDRO-1H-IZOHINOLINA | |
PH12018500903A1 (en) | Pyranodipyridine compound | |
UA113086C2 (en) | PRAZOLE COMPOUNDS AS SGLT1 INHIBITORS | |
PH12016500461A1 (en) | Polyethylene glycol-containing composition | |
EA201890534A1 (en) | NEW ANNELED PHENOXYCETAMIDES | |
JOP20200030A1 (en) | Pentacyclic compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM |